Sign in to view content

Hereditary Retinal Disease & Genetics Take-Home Panel

David Sarraf, MD

Video
Published 2019

Hereditary Retinal Disease & Genetics Take-Home Panel

Related

BVA Analysis of Low- or High-Dose MCO-010 Optogenetics Therapy for Retinitis Pigmentosa: First Time 100-Week TOPLINE Results From a Phase 2b/3 Clinical trial (RESTORE)
Michael A. Singer, MD
Updates from the Field
2024
Subretinal AGTC-501 Gene Therapy for XLRP: 12-Month Interim Safety & Efficacy Results of the Randomized Controlled Multicenter Phase 2 Skyline Trial
Rajiv Anand, MD, FRCS, FASRS
Annual Meeting Talks
2024
Clinical Presentantion and Management of Coats-like Exudative Vitreoretinopathy in Retinitis Pigmentosa
Cagri G Besirli, MD, PhD, FASRS
On Demand Cases, Courses, and Papers
2020

Category: Hereditary Retinal Disease & Genetics

See more